Viewing Study NCT00250861


Ignite Creation Date: 2025-12-24 @ 11:50 AM
Ignite Modification Date: 2026-01-09 @ 11:01 AM
Study NCT ID: NCT00250861
Status: TERMINATED
Last Update Posted: 2008-04-21
First Post: 2005-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Sponsor: US Oncology Research
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module